SEC Company Response from PAVmed Inc. (PAVM) (CIK 0001624326) (PAVM) — Apr 11, 2025
PAVmed Inc. (PAVM) (CIK 0001624326)
Date: April 11, 2025 · CIK: 0001624326 · Accession: 0001641172-25-003761
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-283994
Letter
PAVmed Inc.
Madison Avenue, 25 th Floor
New York, New York 10017
April 11, 2025
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
F Street, N.E.
Washington, D.C. 20549
Attention: Juan Grana
Re:
PAVmed Inc.
Registration Statement on Form S-3
File No. 333-283994
Ladies and Gentlemen:
PAVmed Inc. hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the above-referenced Registration Statement so that such Registration Statement will become effective as of 9:30 a.m., Tuesday, April 15, 2025, or as soon thereafter as practicable.
Very truly yours,
PAVMED INC.
Show Raw Text
CORRESP 1 filename1.htm PAVmed Inc. 360 Madison Avenue, 25 th Floor New York, New York 10017 April 11, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, D.C. 20549 Attention: Juan Grana Re: PAVmed Inc. Registration Statement on Form S-3 File No. 333-283994 Ladies and Gentlemen: PAVmed Inc. hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the above-referenced Registration Statement so that such Registration Statement will become effective as of 9:30 a.m., Tuesday, April 15, 2025, or as soon thereafter as practicable. Very truly yours, PAVMED INC. By: /s/ Lishan Aklog, M.D. Name: Lishan Aklog, M.D. Title: Chairman and Chief Executive Officer